Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy
Ghorab, A., Diab, M., Abdelfattah, N., Elmenshawy, W. (2020). Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy. EKB Journal Management System, 80(1), 627-632. doi: 10.21608/ejhm.2020.92541
Adel Abd ElMohsen Ghorab; Magda Elsayed Diab; Nermin Raafat Abdelfattah; Walaa Refaat Elmenshawy. "Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy". EKB Journal Management System, 80, 1, 2020, 627-632. doi: 10.21608/ejhm.2020.92541
Ghorab, A., Diab, M., Abdelfattah, N., Elmenshawy, W. (2020). 'Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy', EKB Journal Management System, 80(1), pp. 627-632. doi: 10.21608/ejhm.2020.92541
Ghorab, A., Diab, M., Abdelfattah, N., Elmenshawy, W. Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy. EKB Journal Management System, 2020; 80(1): 627-632. doi: 10.21608/ejhm.2020.92541

Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy

The Egyptian Journal of Hospital Medicine
Article 12, Volume 80, Issue 1, July 2020, Page 627-632  XML PDF (474.84 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2020.92541
View on SCiNiTO View on SCiNiTO
Authors
Adel Abd ElMohsen Ghorab1; Magda Elsayed Diab2; Nermin Raafat Abdelfattah3; Walaa Refaat Elmenshawy* 2
1Department of Internal Medicine & Nephrology, Faculty of Medicine, Zagazig University
2Department of Internal Medicine, Faculty of Medicine, Zagazig University
3Department of Medical Biochemistry, Faculty of Medicine, Zagazig University
Abstract
Background: Diabetic nephropathy is one of the major complications of diabetes and the leading cause of end-stage renal disease. Objectives: The main aim of the study was evaluation of urinary podocalyxin as a non-invasive marker for early detection of diabetic nephropathy, through assessing the level of urinary podocalyxin in patients with diabetic nephropathy and assessment of the correlation between urinary podocalyxin levels and severity & grades of diabetic nephropathy. Patient and methods: A prospective cohort study that was conducted in Internal Medicine Department in Zefta General Hospital and Zagazig University Hospital on 42 cases of diabetic nephropathy. Urinary podocalyxin was estimated by using commercially available podocalyxin ELISA test according to the manufacturer’s instructions. Results: The study showed that the area under the curve for validity of podocalyxin was measured to be 0.996. Also, there was significant association and agreement with sensitivity 97.6% and specificity 100%. Conclusion: Podocalyxin is a sensitive and valid marker in diabetic nephropathy that can be used for early detection of diabetic nephropathy in its early stages and can predict the prognosis of nephropathy.
Keywords
Diabetic Nephropathy; Prospective Cohort; Podocalyxin
Statistics
Article View: 270
PDF Download: 548